FDA PMA FDA Class 3 Approved 🇺🇸 United States

Automated Insulin Dosing , Threshold Suspend

PMA: P120010 · Supplement: S046 · Decision Oct 2, 2015
Classifications
1
FEI Numbers
18
Registration Numbers
18

Basic Information

Device Name
Automated Insulin Dosing , Threshold Suspend
Trade Name
MINIMED 530G INSULIN PUMP
PMA Number
P120010
Supplement Number
S046
Device Class
FDA Class 3
Product Code
OZO
Generic Name
Automated insulin dosing , threshold suspend
Medical Specialty
Unknown
Advisory Committee
Clinical Chemistry
Decision
Approved
Decision Code
APPR
Decision Date
October 2, 2015
Date Received
December 10, 2014
Supplement Type
Panel Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N
Docket Number
15M-4013

Advisory Committee Statement

APPROVAL FOR THE MINIMED 530G SYSTEM WITH THRESHOLD SUSPEND FEATURING SMARTGUARD TECHNOLOGY. THIS DEVICE IS INDICATED FOR THE FOLLOWING:THE MINIMED 530G SYSTEM IS INTENDED FOR CONTINUOUS DELIVERY OF BASAL INSULIN (AT USER SELECTABLE RATES) AND ADMINISTRATION OF INSULIN BOLUSES (IN USER SELECTABLE AMOUNTS) FOR THE MANAGEMENT OF DIABETES MELLITUS IN PERSONS, SIXTEEN YEARS OF AGE AND OLDER, REQUIRING INSULIN AS WELL AS FOR THE CONTINUOUS MONITORING AND TRENDING OF GLUCOSE LEVELS IN THE FLUID UNDER THE SKIN. THE MINIMED 530G SYSTEM CAN BE PROGRAMMED TO AUTOMATICALLY SUSPEND DELIVERY OF INSULIN WHEN THE SENSOR GLUCOSE VALUE FALLS BELOW A PREDEFINED THRESHOLD VALUE. THE MINIMED 530G SYSTEM CONSISTS OF THE FOLLOWING DEVICES THAT CAN BE USED IN COMBINATION OR INDIVIDUALLY: MINIMED 530G INSULIN PUMP, ENLITE SENSOR, ENLITE SERTER, THE MINILINK REAL-TIME SYSTEM, THE BAYER CONTOUR NEXTLINK GLUCOSE METER, CARELINK PROFESSIONAL THERAPY MANAGEMENT SOFTWARE FOR DIABETES, AND CARELINK PERSONAL THERAPY MANAGEMENT SOFTWARE FOR DIABETES. THE SYSTEM REQUIRES A PRESCRIPTION.THE MINIMED 530G SYSTEM IS NOT INTENDED TO BE USED DIRECTLY FOR MAKING THERAPY ADJUSTMENTS, BUT RATHER TO PROVIDE AN INDICATION OF WHEN A FINGER STICK MAY BE REQUIRED. ALL THERAPY ADJUSTMENTS SHOULD BE BASED ON MEASUREMENTS OBTAINED USING A HOME GLUCOSE MONITOR AND NOT ON VALUES PROVIDED BY THE MINIMED 530G SYSTEM. THE MINIMED 530G SYSTEM IS NOT INTENDED TO BE USED DIRECTLY FOR PREVENTING OR TREATING HYPOGLYCEMIA BUT TO SUSPEND INSULIN DELIVERY WHEN THE USER IS UNABLE TO RESPOND TO THETHRESHOLD SUSPEND ALARM TO TAKE MEASURES TO PREVENT OR TREAT HYPOGLYCEMIA HIMSELF. THERAPY TO PREVENT OR TREAT HYPOGLYCEMIA SHOULD BE ADMINISTERED ACCORDING TO THERECOMMENDATIONS OF THE USER¿S HEALTH CARE PROVIDER.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OZO Automated Insulin Dosing , Threshold Suspend